COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
Several embodiments pertain to nanoparticle-based compositions and their use in methods for the delivery of active agents to subjects and to products. In several embodiments, the compositions are stable for prolonged periods of time and provide enhanced bioavailability and/or dispersibility.
1 . A nanoparticle composition comprising at least one nanoparticle, the composition comprising at least one active agent, at a weight percent in the composition ranging from 1% to 50%, at least one lipid at a weight percent in the composition ranging from 1% to 50%, optionally at least one surfactant at a weight percent in the composition ranging from 0% to 17.5%, and water at a weight percent in the composition ranging from 50% to about 97.5%.
2 . The nanoparticle composition of claim 1 , wherein the active agent comprises one or more pharmaceutical, nutraceutical, cosmetic, pigment, or flavoring.
3 . The nanoparticle composition of claim 1 , wherein the active agent comprises a plant extract.
4 . The nanoparticle composition of claim 1 , wherein the active agent comprises a cannabis extract, a kanna extract, a kratom extract, an algae extract, and/or a mushroom extract.
5 . The nanoparticle composition of claim 1 , wherein the active agent comprises a small molecule and/or a biologic.
6 .- 8 . (canceled)
9 . The nanoparticle composition of claim 1 , wherein the lipid comprises phosphatidylcholine and/or phosphatidylserine.
10 .- 12 . (canceled)
13 . The nanoparticle composition of claim 1 , wherein the at least one nanoparticle does not comprise a surfactant.
14 . The nanoparticle composition of claim 1 , wherein the composition comprises a mixture of nanoparticles selected from at least two of a multilamellar nanoparticle vesicles, unilamellar nanoparticle vesicles, multivesicular nanoparticles, emulsion particles, irregular particles with lamellar structures and bridges, partial emulsion particles, combined lamellar and emulsion particles, micelles, and/or combinations thereof.
15 . (canceled)
16 . The nanoparticle composition of claim 1 , comprised in a liquid formulation wherein the density of the nanoparticle composition is within 10% of the density of the liquid formulation.
17 . (canceled)
18 . The nanoparticle composition of claim 1 , wherein the at least one nanoparticle comprises phosphatidylcholine, capric and caprylic triglycerides, one or more sterols, vitamin E, potassium sorbate, sodium benzoate, citric acid, and optionally polysorbate 80 and/or polysorbate 20.
19 . A method of manufacturing a nanoparticle composition of claim 1 , the method comprising the steps of:
(a) adding one or more active agents, one or more lipids, and optionally one or more surfactants to water;
(b) mixing the ingredients of step (a) creating a mixture;
(c) homogenizing the mixture creating a homogenized mixture;
(d) performing microfluidization on the homogenized mixture creating a microfluid;
(e) sonicating the microfluid creating a sonicated microfluid;
(f) stirring the sonicated microfluid creating a stirred microfluid;
(g) creating a coacervation from the stirred microfluid; and
(h) precipitating the coacervation.
20 .- 26 . (canceled)
27 . A nanoparticle composition comprising at least one nanoparticle, the composition comprising at least one active agent, at least one lipid, and optionally at least one surfactant at a weight ratio of 1 to 50:1 to 50:0 to 17.5, wherein the composition comprise less than 10 wt. % water.
28 . The nanoparticle composition of claim 27 , wherein the active agent comprises one or more pharmaceutical, nutraceutical, cosmetic, pigment, or flavoring.
29 . The nanoparticle composition of claim 27 , wherein the composition comprises a mixture of nanoparticles selected from at least two of a liposome, a micelle, a nanoemulsion, a multi-lamellar particle, a double liposome particle, and a solid lipid particle.
30 . The nanoparticle composition of claim 27 , wherein the at least one nanoparticle comprises phosphatidylcholine, capric and caprylic triglycerides, one or more sterol, vitamin E, potassium sorbate, sodium benzoate, and citric acid.
31 . A method of treating a disease, a disorder, and/or a symptom in an individual, the method comprising administering to the individual a therapeutically effective amount of the nanoparticle composition of claim 1 .
32 .- 37 . (canceled)
38 . A method of distributing an active agent in a solution, the method comprising contacting the solution with the nanoparticle composition of claim 1 .
39 . The method of claim 38 , wherein the nanoparticle composition has a density within 10% of a density of the solution.
40 . The method of claim 38 , wherein the nanoparticle composition comprises a mixture of nanoparticles selected from at least two of a liposome, a micelle, a nanoemulsion, a multi-lamellar particle, a double liposome particle, and a solid lipid particle.
41 . A method of adjusting a density of the nanoparticle composition of claim 14 , the method comprising adjusting the density by adjusting a ratio of at least two of a liposome, a micelle, a nanoemulsion, a multi-lamellar particle, a double liposome particle, and a solid lipid particle.